BioBusiness.TV |

MASHUP from the 2009 Phacilitate Cell & Gene Therapy Forum

1. How Would You Define Cell Therapy?
2. Are We Going to See New Cell Therapy Products in the Next 2-3 Years?
3. How Many Cell Therapy Products Are On the Market Today?
4. What Are Some of the Exciting Things Happening in Cell Therapy?

Florida Biologix, 60sec Pitch

Florida Biologix, 60sec Pitch Christine Aytug, Director of Marketing and Sales Website: http://www.floridabiologix.ufl.com/ Company Overview Florida Biologix® is a biopharmaceutical contract services provider that specializes in developing, manufacturing, purifying, testing and filling Phase I and II cGMP biologic clinical trial material on time and at a reasonable price. This interview was conducted at the Phacilitate Cell & Gene Therapy Forum 2009, on ...

Maxcyte, 60sec Pitch

Maxcyte, 60sec Pitch Douglas Doerfler, President and CEO Website: http://www.maxcyte.com/ **Company Overview** MaxCyte is a clinical-stage cell therapeutics company with a rapidly growing pipeline of product development partnerships in cell-based therapies. The Company's proprietary, non-viral, ex vivo cell loading technology provides safety, scalability and reproducibility capabilities which are fundamental to commercializing successful cell-based therapies. MaxCyte has demonstrated the value of its ...

Athersys Inc., 60sec Pitch

You are Watching: Athersys Inc., 60sec Pitch Gil Van Bokkelen, Chairman and Chief Executive Officer Website: http://www.athersys.com/ **Company Overview** Athersys is a developing a pipeline of therapeutic products with “best-in-class” potential. The most advanced product in development is MultiStem, a patented and proprietary stem cell therapy that in the past year has reached clinical stage in 3 areas, including treating cardiovascular disease ...

George Poste on the Jan Buck Show

1. Molecular Diagnostics As The Next Major Conceptual Transition
2. Mapping the Human Genome, And The Innovator’s Dilemma In The Pharma Industry
3. Taking Out A Small Number of Pharmaceutical Manufacturing Plants Could Dislocate Medicine Supply For Large Numbers of the Global Population
4. The Biodesign Institute, A Radical Experiment To Extract The Low Intensity Signal That May Be Indicative Of Disease
5. A Look to the Future: Personalized Medicine, Consumer Driven Health, Synthetic Biology

Osiris CEO on the Applications of Mesenchymal Stem Cells

Randy Mills discusses the therapeutical and commercial applications of mesenchymal stem cells with Bill Kridel.

GXDX – Genoptics CEO Tina Nova, Interviewed by Adam Feinstein

Beyond tests, lab service Genoptix provides comprehensive diagnostics, new efficiencies for the healthcare system.

Xoma, Ltd. 60sec Pitch

Xoma, Ltd. 60sec Pitch Steven B. Engle, Chairman and Chief Executive Officer Website: http://www.xoma.com/ Company Overview XOMA discovers, develops and manufactures therapeutic antibody agents designed to treat inflammatory, autoimmune, infectious and cancerous diseases and is engaged in more than 16 active development projects. The Company's expanding pipeline includes XOMA 052, an anti-IL-1beta antibody, and XOMA 629, a synthetic antimicrobial peptide compound ...

ZelosTherapeutics, Inc. 60sec Pitch

ZelosTherapeutics, Inc. 60sec Pitch Brian MacDonald, MB ChB PhD, Chief Executive Officer Website: http://www.zelostherapeutics.com/ Company Overview Zelos Therapeutics is developing therapeutics for the treatment of osteoporosis and other bone diseases. Our lead compound, ZT-031, is entering Phase 3 registration studies and has the potential to become a leading therapy to treat osteoporosis in the growing PTH market. In addition, Zelos Therapeutics ...

Mannkind Corporation, 60sec Pitch

Mannkind Corporation, 60sec Pitch Hakan Edstrom, President, COO & Director Website: http://www.mannkindcorp.com/ Company Overview Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Our lead investigational product candidate, the Technosphere Insulin System, is currently in phase 3 clinical trials in the United States, Europe, and Latin America to ...